GGrantIndex
Sort

17,288 grants matching multiple sclerosis

T Cell costimulation: Induction and Regulation of Autoimmunity

$535,783
Vijay Kuchroo · Harvard Medical School · P01 · FY2017 · AI

Predicting contrast enhancement in multiple sclerosis with real time texture analysis

$535,749
Ponnada A Narayana · University Of Texas Hlth Sci Ctr Houston · R56 · FY2018 · NS

Genetic and non-genetic risk factors in MS

$535,724
University Of California Berkeley · R01 · FY2005 · NS

Environmental and genetic risk factors for pediatric MS

$535,693
Emmanuelle Laurence Waubant · University Of California, San Francisco · R01 · FY2012 · NS

RESTORATIVE NEUROIMMUNOLOGY IN EXPERIMENTAL MODELS OF MULTIPLE SCLEROSIS VIA DIRECTLY INDUCED NEURAL STEM CELL TRANSPLANTATION (MS_INSC)

$535,528
The Chancellor, Masters, And Scholars Of The University Of Cambridge · · FY2015 · Department of the Army

Spatiotemporal interrogation of molecular mechanobiololgy at the cell-cell interface with nanotechnology tools

$535,373
Young-Wook Jun · University Of California, San Francisco · R35 · FY2024 · GM

Spatiotemporal interrogation of molecular mechanobiololgy at the cell-cell interface with nanotechnology tools

$535,373
Young-Wook Jun · University Of California, San Francisco · R35 · FY2021 · GM

Spatiotemporal interrogation of molecular mechanobiololgy at the cell-cell interface with nanotechnology tools

$535,373
Young-Wook Jun · University Of California, San Francisco · R35 · FY2022 · GM

Spatiotemporal interrogation of molecular mechanobiololgy at the cell-cell interface with nanotechnology tools

$535,373
Young-Wook Jun · University Of California, San Francisco · R35 · FY2023 · GM

Improving Adherence with Statins Through Use of the Statin Choice Decision Aid

$535,354
Kathryn Anne Martinez · Cleveland Clinic Lerner Com-Cwru · R56 · FY2022 · HL

Improving Outcomes Assessment in Chronic Graft versus Host Disease

$535,000
Stephanie J Lee · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Repurposing esomeprazole for the treatment of scleroderma

$534,965
Yohannes T Ghebre · University Of Texas Hlth Science Center · R01 · FY2024 · AR

An Enhanced Neurovascular Model with Scanning Conductance Imaging of Cell Junctions to Determine the Role of Matrix Metalloproteases in Multiple Sclerosis

$534,964
Dana M Spence · Michigan State University · R01 · FY2025 · NS

An immunomodulatory approach to improve oral cavity wound healing

$534,642
Steven L Goudy · Emory University · R01 · FY2024 · DE

Quantitative analysis of estrogen and sleep deprivation-induced blood and lymphatic vascular remodeling in the brain system

$534,438
K. Palaniappan · University Of Missouri-Columbia · R01 · FY2021 · NS

Spinocerebellar Ataxia Type 2 Gene and Gene Product

$534,368
Stefan M. Pulst · University Of Utah · R37 · FY2020 · NS

Spinocerebellar Ataxia Type 2 Gene and Gene Product

$534,368
Stefan M. Pulst · University Of Utah · R37 · FY2019 · NS

Spinocerebellar Ataxia Type 2 Gene and Gene Product

$534,368
Stefan M. Pulst · University Of Utah · R37 · FY2018 · NS

Exploring the Functions of tRNA Synthetases in the Nucleus and their Relationship to CMT

$534,169
Xiang-Lei Yang · Scripps Research Institute, The · R01 · FY2022 · NS

CD24 Targeting for Multiple Sclerosis: a First-In-Human Phase I Study

$534,084
Yang Liu · Oncoimmune, Inc. · R01 · FY2014 · NS

Oligodendrocyte-focused rAAV gene therapy strategies for Canavan disease and Leukodystrophies

$533,982
Guang-Ping Gao · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · NS

Mechanotransduction Control of CNS Myelin Sheath Length.

$533,763
Marie E Bechler · Upstate Medical University · R01 · FY2024 · NS

Quantitative evaluation of myelin damage in cervical spinal cord

$533,750
Eun-Kee Jeong · University Of Utah · R56 · FY2018 · NS

Translation of In-Clinic Gains to Gains in Daily Life

$533,722
Catherine E Lang · Washington University · R37 · FY2023 · HD

CAREER: A systems engineering approach to elucidate and treat multi-factorial pathology

$533,682
Cassie S Mitchell · Georgia Tech Research Corporation · · FY2020 · ENG